chlorfenethol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 6624 |
CHEMBL ID | 1522056 |
CHEBI ID | 82154 |
SCHEMBL ID | 26402 |
MeSH ID | M0046180 |
Synonym |
---|
quickron |
p,p'-dichlorodiphenylmethylcarbinol |
qikron |
bis(4-chlorophenyl)methylcarbinol |
nsc2848 |
dimit |
ethanol,1-bis(p-chlorophenyl)- |
nsc-2848 |
1,1-bis(p-chlorophenyl)ethanol |
micasin |
BPE , |
dimite |
dichlorodiphenylethanol |
wln: gr dxq1&r dg |
80-06-8 |
1,1-bis(4-chlorophenyl)ethanol |
chlorfenethol |
4,4'-dichloro-.alpha.-methylbenzohydrol |
1,1-bis(p-chlorophenyl)methylcarbinol |
bis(p-chlorophenyl)methylcarbinol |
di(p-chlorophenyl)methyl carbinol |
benzenemethanol, 4-chloro-.alpha.-(4-chlorophenyl)-.alpha.-methyl- |
di(p-chlorophenyl)ethanol |
ent 9,624 |
benzhydrol,4'-dichloro-.alpha.-methyl- |
bcpe |
4,4'-dichloromethylbenzhydrol |
dcpc |
dcpe |
4,4'-dichloro-.alpha.-methylbenzhydrol |
mikazene |
1,1-bis(p-chorophenyl)ethanol |
einecs 201-246-3 |
bcpe (pesticide) |
nsc 2848 |
bis(p-chlorophenyl)methyl carbinol |
ai3-09624 |
ethanol, 1,1-bis(p-chlorophenyl)- |
chlorfenethol [iso:bsi] |
brn 2505345 |
benzenemethanol, 4-chloro-alpha-(4-chlorophenyl)-alpha-methyl- |
4,4'-dichloro-alpha-methylbenzohydrol |
di(p-chlorophenyl) methylcarbinol |
4,4'-dichloro-alpha-methylbenzhydrol |
epa pesticide chemical code 031101 |
4-chloro-alpha-(4-chlorophenyl)-alpha-methylbenzenemethanol |
4,4'-dichloro-(methyl benzhydrol) |
caswell no. 310 |
di-(p-chlorophenyl)-ethanol |
dcpc (van) |
benzhydrol, 4,4'-dichloro-alpha-methyl- |
1,1-bis(4-chlorphenyl)-aethanol [german] |
dmc (van) |
hsdb 1569 |
NCGC00166131-01 |
D2692 |
AKOS000120878 |
C19023 |
cas-80-06-8 |
dtxsid7040283 , |
dtxcid5020283 |
NCGC00255609-01 |
tox21_301458 |
1,1-bis(4-chlorphenyl)-aethanol |
unii-l0079fa965 |
l0079fa965 , |
1,1-bis(4-chlorophenyl)ethan-1-ol |
FT-0623602 |
4,4'-dichloro-.alpha.-methylbenzhydryl alcohol |
chlorfenethol [mi] |
chlorfenethol [iso] |
SCHEMBL26402 |
CHEBI:82154 , |
mfcd00000628 |
benzhydrol, 4,4'-dichloro-.alpha.-methyl- |
URYAFVKLYSEINW-UHFFFAOYSA-N |
CHEMBL1522056 |
chlorfenethol, pestanal(r), analytical standard |
Q1920106 |
Class | Description |
---|---|
diarylmethane | Any compound containing two aryl groups connected by a single C atom. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 61.6448 | 3.1890 | 29.8841 | 59.4836 | AID1224846 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 10.2626 | 0.0060 | 38.0041 | 19,952.5996 | AID1159523 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 40.1978 | 0.0007 | 14.5928 | 83.7951 | AID1259369; AID1259392 |
AR protein | Homo sapiens (human) | Potency | 35.0913 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243; AID1259247; AID743035; AID743054; AID743063 |
caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 68.5896 | 0.0133 | 26.9810 | 70.7614 | AID1346978 |
estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 54.4827 | 0.0006 | 57.9133 | 22,387.1992 | AID1259378 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 9.6248 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224839; AID1224893 |
progesterone receptor | Homo sapiens (human) | Potency | 9.6885 | 0.0004 | 17.9460 | 75.1148 | AID1346795 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 5.4941 | 0.0002 | 14.3764 | 60.0339 | AID720692 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 61.1306 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 7.2084 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 57.9611 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 27.3060 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 49.6962 | 0.0002 | 29.3054 | 16,493.5996 | AID1259244; AID1259248; AID743069; AID743091 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 61.6448 | 0.0010 | 19.4141 | 70.9645 | AID743191 |
caspase-3 | Homo sapiens (human) | Potency | 68.5896 | 0.0133 | 26.9810 | 70.7614 | AID1346978 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 61.1306 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 68.5896 | 0.0016 | 28.0151 | 77.1139 | AID1224895 |
activating transcription factor 6 | Homo sapiens (human) | Potency | 61.6448 | 0.1434 | 27.6121 | 59.8106 | AID1159516; AID1159519 |
thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 33.8260 | 0.1549 | 17.8702 | 43.6557 | AID1346877 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 54.9410 | 19.7391 | 45.9784 | 64.9432 | AID1159509 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 38.7896 | 0.0578 | 21.1097 | 61.2679 | AID1159526; AID1159528 |
Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 113.0040 | 0.0391 | 47.5451 | 146.8240 | AID1224845 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 42.5085 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 64.8601 | 0.0006 | 27.2152 | 1,122.0200 | AID743202; AID743219 |
nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 25.1189 | 0.0079 | 8.2332 | 1,122.0200 | AID2546 |
Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 43.2771 | 0.0015 | 57.7890 | 15,848.9004 | AID1259244 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 6.8590 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 43.2771 | 0.0015 | 51.7393 | 15,848.9004 | AID1259244 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.98) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |